![Tim Demuth](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tim Demuth
Direttore Tecnico/Scientifico/R&S presso MORPHOSYS AG
Profilo
Tim Demuth is currently the Chief Research & Development Officer at MorphoSys AG since 2022.
Prior to this, he was the Chief Medical Officer & Senior Vice President at Pieris Pharmaceuticals, Inc. from 2021 to 2022.
He also held positions as VP & Head-Global Clinical Development Oncology at Merck KGaA and Head-Clinical Development at Sandoz AG.
Dr. Demuth obtained a doctorate degree from The Johannes Gutenberg University of Mainz.
Posizioni attive di Tim Demuth
Società | Posizione | Inizio |
---|---|---|
MORPHOSYS AG | Direttore Tecnico/Scientifico/R&S | 01/10/2022 |
Precedenti posizioni note di Tim Demuth
Società | Posizione | Fine |
---|---|---|
PIERIS PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 30/09/2022 |
Sandoz AG
![]() Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Direttore Tecnico/Scientifico/R&S | - |
MERCK KGAA | Corporate Officer/Principal | - |
Formazione di Tim Demuth
The Johannes Gutenberg University of Mainz | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
PIERIS PHARMACEUTICALS, INC. | Health Technology |
MERCK KGAA | Health Technology |
MORPHOSYS AG | Health Technology |
Aziende private | 1 |
---|---|
Sandoz AG
![]() Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Tim Demuth